The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is a huge mover today! About 19.07M shares traded hands or 78.06% up from the average. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 26.26% since April 13, 2016 and is downtrending. It has underperformed by 30.19% the S&P500.
The move comes after 7 months negative chart setup for the $38.90B company. It was reported on Nov, 15 by Barchart.com. We have $36.15 PT which if reached, will make NYSE:TEVA worth $1.95B less.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Ratings Coverage
Out of 20 analysts covering Teva Pharma (NYSE:TEVA), 14 rate it a “Buy”, 0 “Sell”, while 6 “Hold”. This means 70% are positive. Teva Pharma has been the topic of 33 analyst reports since July 21, 2015 according to StockzIntelligence Inc. The firm has “Outperform” rating given on Friday, February 19 by Wells Fargo. As per Friday, September 2, the company rating was upgraded by Oppenheimer. As per Monday, October 31, the company rating was upgraded by Credit Suisse. The firm earned “Overweight” rating on Monday, August 3 by JP Morgan. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Buy” rating given on Monday, November 23 by Goldman Sachs. Citigroup maintained the shares of TEVA in a report on Tuesday, July 28 with “Buy” rating. The company was downgraded on Friday, November 4 by HSBC. As per Wednesday, July 29, the company rating was maintained by RBC Capital Markets. Morgan Stanley reinitiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) rating on Wednesday, July 29. Morgan Stanley has “Overweight” rating and $85.0 price target. As per Tuesday, July 28, the company rating was maintained by Argus Research.
According to Zacks Investment Research, “TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.”
Another recent and important Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) news was published by Investorplace.com which published an article titled: “Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Falls Despite Q3 …” on November 15, 2016.
TEVA Company Profile
Teva Pharmaceutical Industries Limited, incorporated on February 13, 1944, is a global pharmaceutical company. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Firm operates through two divisions: Generic medicines and Specialty medicines. The Firm has a global portfolio of approximately 1,000 molecules.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.